Related Experiment Video
Updated: Aug 13, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists
1Department of Genetics, University of Illinois, Chicago 60612.
Abstract:
P-glycoprotein, encoded by the MDR1 (multidrug resistance) gene, is a transmembrane efflux pump for various lipophilic compounds. MDR1 is expressed in several types of normal human tissues and in a variety of tumors, where its expression has been correlated with resistance to chemotherapy. Some P-glycoprotein-overexpressing multidrug-resistant cell lines contain elevated amounts of protein kinase C (PKC). PKC activation was shown to increase the level of drug resistance in several cell lines, but the functional association of PKC with P-glycoprotein-mediated multidrug resistance remains unclear. We have studied the effects of lymphocyte-activating agents on P-glycoprotein activity in normal human lymphocytes, and found that 12-O-tetradecanoylphorbol-13-acetate (TPA), an efficient agonist of PKC, increased the activity as well as the levels of P-glycoprotein in these cells. TPA also increased P-glycoprotein expression in several cell lines derived from different types of leukemias and solid tumors. The increase in MDR1 gene expression was observed at both the protein and RNA levels. Induction of MDR1 mRNA was apparent as early as two hours after the addition of TPA. Diacylglycerol (DAG), a physiological stimulant of PKC, also increased the expression of MDR1 mRNA and P-glycoprotein. The induction of MDR1 expression by TPA and DAG was suppressed by staurosporine, a protein kinase inhibitor. The results suggest that MDR1 gene expression in different cell types is regulated by a PKC-mediated pathway. This finding has implications for the emergence of multidrug resistance in vitro and in vivo.
Insights
Protein kinase C (PKC) activation by agents like TPA increases P-glycoprotein and MDR1 gene expression. This suggests a PKC-mediated pathway regulates multidrug resistance in various cell types.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- P-glycoprotein, encoded by the MDR1 gene, is a transmembrane efflux pump.
- MDR1 expression is linked to multidrug resistance in tumors and chemotherapy resistance.
- Elevated protein kinase C (PKC) is observed in some multidrug-resistant cells, but its role is unclear.
Purpose of the Study:
- To investigate the effects of lymphocyte-activating agents on P-glycoprotein activity.
- To determine the functional association of PKC with P-glycoprotein-mediated multidrug resistance.
Main Methods:
- Studied P-glycoprotein activity in normal human lymphocytes using TPA, a PKC agonist.
- Examined P-glycoprotein expression in leukemia and solid tumor cell lines.
- Measured MDR1 gene expression at protein and RNA levels.
- Utilized diacylglycerol (DAG) and staurosporine for further investigation.
Main Results:
- TPA increased P-glycoprotein activity and levels in lymphocytes.
- TPA elevated P-glycoprotein expression in various cancer cell lines.
- MDR1 gene expression (mRNA and protein) increased upon TPA and DAG treatment.
- PKC inhibitor staurosporine suppressed TPA/DAG-induced MDR1 expression.
Conclusions:
- MDR1 gene expression appears to be regulated by a PKC-mediated pathway.
- This pathway plays a role in the development of multidrug resistance in vitro and in vivo.
Related Concept Videos
Mitogens and the Cell Cycle
Abnormal Proliferation
MAPK Signaling Cascades
GPCRs Regulate Adenylyl Cylase Activity
Two...
cAMP-dependent Protein Kinase Pathways
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...

